-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The severity of 2019 new coronary pneumonia ( COVID-19 ) varies from person to person, ranging from asymptomatic infection to acute respiratory distress syndrome that requires mechanical ventilation
The new crown pneumonia COVID-19 infection
Due to SARS-CoV-2 infection caused by renal proximal tubule dysfunction and accompanied by uric acid loss, a research article was published in Critical Care, an authoritative journal in the field of critical care medicine.
The researchers conducted a retrospective study using two independent cohorts to investigate and verify the prevalence, kinetics, and clinical relevance of hypouricemia in patients hospitalized with COVID-19 in a large teaching hospital in Brussels, Belgium
The discovery and verification cohorts included 192 and 325 patients hospitalized with COVID-19, respectively
It can be seen that in COVID-19 patients requiring hospitalization, low serum uric acid levels are common and are associated with the severity of the disease and progression to respiratory failure requiring invasive mechanical ventilation
In COVID-19 patients requiring hospitalization, low serum uric acid levels are common and are associated with disease severity and progression to respiratory failure requiring invasive mechanical ventilation
Original source:
Original source:Inès Dufour.
Serum uric acid, disease severity and outcomes in COVID-19
Leave a message here